Olivier Espitia Selected Research

Olivier Espitia Research Topics

Disease

8	Neoplasms (Cancer) 11/2023 - 01/2021
4	Giant Cell Arteritis (Horton Disease) 04/2024 - 01/2016
4	Infections 11/2023 - 10/2012
4	Thrombosis (Thrombus) 11/2023 - 01/2021
4	Venous Thrombosis (Deep-Vein Thrombosis) 09/2023 - 01/2021
4	Thromboangiitis Obliterans (Buerger's Disease) 07/2021 - 12/2018
3	Aneurysm (Aneurysms) 12/2023 - 04/2023
3	Aortitis 12/2023 - 09/2019
3	Venous Thromboembolism 11/2023 - 01/2017
3	Takayasu Arteritis (Arteritis, Takayasu's) 10/2023 - 11/2022
3	Vasculitis (Vasculitides) 12/2022 - 09/2019
2	Necrosis 12/2023 - 01/2018
2	Aortic Aneurysm (Aneurysm, Aortic) 12/2023 - 11/2012
2	Hemorrhage 11/2023 - 09/2023
2	Inflammation (Inflammations) 04/2023 - 10/2019
2	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 05/2021
1	Aortic Dissection 12/2023
1	Communicable Diseases (Infectious Diseases) 11/2023
1	Pulmonary Embolism 11/2023
1	Upper Extremity Deep Vein Thrombosis 11/2023
1	Ischemia 06/2023
1	Popliteal Artery Aneurysm 06/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Postthrombotic Syndrome 01/2023
1	Oropharyngeal Neoplasms 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Vascular Malformations 12/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Hypertension (High Blood Pressure) 05/2021
1	Pregnancy Complications 01/2021
1	Bronchitis 01/2021
1	Hypercholesterolemia 01/2021
1	Infarction (Infarctions) 01/2021
1	Neutropenia 01/2021
1	Pyelonephritis 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2017
1	Myocardial Infarction 01/2017
1	Erythema elevatum diutinum 12/2016
1	Arthritis (Polyarthritis) 11/2014
1	Osteoporosis 10/2012

Drug/Important Bio-Agent (IBA)

5	tocilizumab (atlizumab)FDA Link 01/2023 - 01/2016
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2024 - 12/2022
3	SteroidsIBA 06/2023 - 10/2012
3	Troleandomycin (TAO)FDA Link 07/2021 - 01/2021
2	Prednisone (Sone)FDA LinkGeneric 12/2023 - 09/2019
2	AnticoagulantsIBA 11/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2022
2	Rituximab (Mabthera)FDA Link 10/2023 - 01/2018
1	Methylprednisolone FDA LinkGeneric 12/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023
1	N 30IBA 12/2023
1	IronIBA 11/2023
1	Factor Xa InhibitorsIBA 11/2023
1	Fondaparinux (Arixtra)FDA Link 11/2023
1	fibrin fragment D (D-dimer)IBA 11/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2023
1	GlucocorticoidsIBA 04/2023
1	B7-H1 AntigenIBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2021
1	CreatinineIBA 01/2021
1	omega-Chloroacetophenone (Mace)IBA 10/2019
1	Tumor Necrosis Factor InhibitorsIBA 01/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018
1	Abatacept (Orencia)FDA Link 01/2018
1	Antirheumatic Agents (DMARD)IBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2017
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2017
1	Thrombin FDA Link 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Immunoglobulin M (IgM)IBA 12/2016
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2014

Therapy/Procedure

6	Catheters 11/2023 - 01/2021
2	Central Venous Catheters 11/2023 - 01/2021
2	Stents 06/2023 - 01/2023
2	Therapeutics 01/2023 - 12/2022
1	Thrombectomy 06/2023
1	Vena Cava Filters (Inferior Vena Cava Filter) 01/2023
1	Sclerotherapy 12/2022
1	Cryosurgery 12/2022
1	Immunotherapy 01/2022
1	Drug Tapering 01/2021
1	Endarterectomy (Thromboendarterectomy) 10/2019
1	Surgical Amputation (Amputations) 12/2018
1	Bed Rest (Bedrest) 01/2017